CLOSED
Emkay Global Financial Services maintains its 'Buy' rating on Park Medi World, raising the target price to ₹375 following strong June quarter results, with revenue growth of 19% YoY and profit after tax increasing by 31%. Capacity expands amid risks in government collections.
Stock to buy after Q1 results 2026: Emkay sees over 32% upside in this healthcare stock
Impact Score
Market Sentiment
↑BullishPrimary Sectors
Emkay Global Financial Services maintains its 'Buy' rating on Park Medi World, raising the target price to ₹375 following strong June quarter results, with revenue growth of 19% YoY and profit after tax increasing by 31%. Capacity expands amid risks in government collections.
Key Highlights
Emkay Global Financial Services maintains its 'Buy' rating on Park Medi World, raising the target price to ₹375 following strong June quarter results, with revenue growth of 19% YoY and profit after tax increasing by 31%.
Capacity expands amid risks in government collections..
Source
Livemint
Published
2h ago
Impact Score
75 / 100
Category
Corporate Earnings
Positive near-term momentum expected in Corporate Earnings as market digests this development.
What this means
No linked events found.